Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2023

17-03-2023 | Diabetes | Research article

The prevalence of uncontrolled diabetes mellitus in patients with type 2 diabetes: a multicenter cross-sectional study

Authors: Monir Lorestanifar, Masoomeh Mosayebi Molasaraei, Reyhaneh Jashaninejad, Saman Khoshmanesh, Amin Doosti-Irani

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2023

Login to get access

Abstract

Purpose

The prevalence of diabetes is increasing worldwide. Studies have shown that poor blood sugar control is associated with the complications of diabetes, we aimed to determine the prevalence of uncontrolled diabetes mellitus (UDM) and its related factors.

Methods

This multicenter cross-sectional study was conducted in 2021 on type 2 diabetic patients in three cities; Rasht (in Gillan province), Borujerd (in Lorestan province), and Khodabandeh (in Zanjan province). A predesigned checklist was used to extract the basic characteristics of participants, their hemoglobin A1C, and other required data from their medical records. The prevalence of uncontrolled diabetes was reported with a 95% Confidence Interval.

Results

In this study, the medical records of 460 patients with type 2 diabetes were included. The mean and standard deviation (SD) of the age of participants was 59.17 (11.59), and 73.2% (337) of participants were female. The prevalence of UDM in Rasht, Borujerd, and Khodabandeh was 58.27%, 69.38%, and 45.65% respectively. The prevalence of UDM in obese patients was 64.78% (57.03, 71.82). Based on the results of the adjusted model, an increase in diastolic blood pressure was significantly associated with UDM, meaning each unit increase in diastolic blood pressure was associated with a 3% increase in UDM (95% CI: 1.01, 1.06), adjusted for age, gender and education.

Conclusion

According to these results, the prevalence of UDM among patients with diabetes is high. Diastolic blood pressure and low level of education were associated with UDM in diabetic patients.
Literature
1.
go back to reference Pappas Y, Wei I, Car J, Majeed A, Sheikh A. Computer-assisted versus oral‐and‐written family history taking for identifying people with elevated risk of type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2011(12). Pappas Y, Wei I, Car J, Majeed A, Sheikh A. Computer-assisted versus oral‐and‐written family history taking for identifying people with elevated risk of type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2011(12).
4.
go back to reference Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet (London England). 2021;396(10267):2019–82.CrossRefPubMed Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet (London England). 2021;396(10267):2019–82.CrossRefPubMed
5.
go back to reference Olaniyi EO, Adnan K, editors., editors. Onset Diabetes Diagnosis Using Artificial Neural Network2015. Olaniyi EO, Adnan K, editors., editors. Onset Diabetes Diagnosis Using Artificial Neural Network2015.
6.
go back to reference Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes research and clinical practice. 2019;157:107843. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes research and clinical practice. 2019;157:107843.
7.
go back to reference Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49.CrossRefPubMed Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49.CrossRefPubMed
8.
go back to reference Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract. 2014;103(2):319–27.CrossRefPubMed Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract. 2014;103(2):319–27.CrossRefPubMed
9.
go back to reference Riaz F, Al Shaikh A, Anjum Q, Mudawi Alqahtani Y, Shahid S. Factors related to the uncontrolled fasting blood sugar among type 2 diabetic patients attending primary health care center, Abha city, Saudi Arabia. Int J Clin Pract. 2021;75(7):e14168.CrossRefPubMed Riaz F, Al Shaikh A, Anjum Q, Mudawi Alqahtani Y, Shahid S. Factors related to the uncontrolled fasting blood sugar among type 2 diabetic patients attending primary health care center, Abha city, Saudi Arabia. Int J Clin Pract. 2021;75(7):e14168.CrossRefPubMed
10.
go back to reference Siddiqui FJ, Avan BI, Mahmud S, Nanan DJ, Jabbar A, Assam PN. Uncontrolled diabetes mellitus: prevalence and risk factors among people with type 2 diabetes mellitus in an Urban District of Karachi, Pakistan. Diabetes Res Clin Pract. 2015;107(1):148–56.CrossRefPubMed Siddiqui FJ, Avan BI, Mahmud S, Nanan DJ, Jabbar A, Assam PN. Uncontrolled diabetes mellitus: prevalence and risk factors among people with type 2 diabetes mellitus in an Urban District of Karachi, Pakistan. Diabetes Res Clin Pract. 2015;107(1):148–56.CrossRefPubMed
11.
go back to reference Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20(1):166.CrossRefPubMedPubMedCentral Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20(1):166.CrossRefPubMedPubMedCentral
12.
go back to reference Alkout AM, Blackwell CC, Weir DM. Increased inflammatory responses of persons of blood group O to Helicobacter pylori. J Infect Dis. 2000;181(4):1364–9.CrossRefPubMed Alkout AM, Blackwell CC, Weir DM. Increased inflammatory responses of persons of blood group O to Helicobacter pylori. J Infect Dis. 2000;181(4):1364–9.CrossRefPubMed
13.
go back to reference Liu ZM, Ho SC. The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in chinese postmenopausal women with prediabetes or early untreated diabetes. Maturitas. 2011;70(2):176–81.CrossRefPubMed Liu ZM, Ho SC. The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in chinese postmenopausal women with prediabetes or early untreated diabetes. Maturitas. 2011;70(2):176–81.CrossRefPubMed
14.
go back to reference Murugesan N, Snehalatha C, Shobhana R, Roglic G, Ramachandran A. Awareness about diabetes and its complications in the general and diabetic population in a city in southern India. Diabetes Res Clin Pract. 2007;77(3):433–7.CrossRefPubMed Murugesan N, Snehalatha C, Shobhana R, Roglic G, Ramachandran A. Awareness about diabetes and its complications in the general and diabetic population in a city in southern India. Diabetes Res Clin Pract. 2007;77(3):433–7.CrossRefPubMed
15.
go back to reference Kassaian SE, Goodarzynejad H, Boroumand MA, Salarifar M, Masoudkabir F, Mohajeri-Tehrani MR, et al. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol. 2012;11(1):82.CrossRefPubMedPubMedCentral Kassaian SE, Goodarzynejad H, Boroumand MA, Salarifar M, Masoudkabir F, Mohajeri-Tehrani MR, et al. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol. 2012;11(1):82.CrossRefPubMedPubMedCentral
16.
go back to reference Kogani M, Mansournia MA, Doosti-Irani A, Holakouie-Naieni K. Risk factors for amputation in patients with diabetic foot ulcer in southwest Iran: a matched case-control study. Epidemiol Health. 2015;37(0):e2015044–0.CrossRefPubMedPubMedCentral Kogani M, Mansournia MA, Doosti-Irani A, Holakouie-Naieni K. Risk factors for amputation in patients with diabetic foot ulcer in southwest Iran: a matched case-control study. Epidemiol Health. 2015;37(0):e2015044–0.CrossRefPubMedPubMedCentral
17.
go back to reference Ahmadi Tabatabai SV, Esmailinejad AS, Sadeghi R, Zeidabadi B. Factors influencing the consumption of fruits and vegetables in diabetic patients based on Pender’s health promotion model. J Educ health promotion. 2022;11:51. Ahmadi Tabatabai SV, Esmailinejad AS, Sadeghi R, Zeidabadi B. Factors influencing the consumption of fruits and vegetables in diabetic patients based on Pender’s health promotion model. J Educ health promotion. 2022;11:51.
18.
go back to reference Koçak MZ, Aktas G, Erkus E, Duman TT, SAVLİ H. Analysis of the type 2 diabetic patients followed in a university clinic. Konuralp Med J. 2018;10(2):198–202. Koçak MZ, Aktas G, Erkus E, Duman TT, SAVLİ H. Analysis of the type 2 diabetic patients followed in a university clinic. Konuralp Med J. 2018;10(2):198–202.
19.
go back to reference Brož J, Janíčková Žďárská D, Urbanová J, Brabec M, Doničová V, Štěpánová R, et al. Current level of glycemic control and clinical inertia in subjects using insulin for the treatment of type 1 and type 2 diabetes in the Czech Republic and the Slovak Republic: results of a multinational, multicenter, observational survey (DIAINFORM). Diabetes Therapy. 2018;9(5):1897–906.CrossRefPubMedPubMedCentral Brož J, Janíčková Žďárská D, Urbanová J, Brabec M, Doničová V, Štěpánová R, et al. Current level of glycemic control and clinical inertia in subjects using insulin for the treatment of type 1 and type 2 diabetes in the Czech Republic and the Slovak Republic: results of a multinational, multicenter, observational survey (DIAINFORM). Diabetes Therapy. 2018;9(5):1897–906.CrossRefPubMedPubMedCentral
20.
go back to reference Ghavami H, Radfar M, Soheily S, Shamsi SA, Khalkhali HR. Effect of lifestyle interventions on diabetic peripheral neuropathy in patients with type 2 diabetes, result of a randomized clinical trial. Agri: Agri (Algoloji) Dernegi’nin Yayin organidir = the. J Turkish Soc Algology. 2018;30(4):165–70. Ghavami H, Radfar M, Soheily S, Shamsi SA, Khalkhali HR. Effect of lifestyle interventions on diabetic peripheral neuropathy in patients with type 2 diabetes, result of a randomized clinical trial. Agri: Agri (Algoloji) Dernegi’nin Yayin organidir = the. J Turkish Soc Algology. 2018;30(4):165–70.
21.
go back to reference Hashemipour M, Hovsepian S, Mozafarian N, Motaghi Z, Izadikhah E, Maracy MR. Factors related to glycemic control in children and adolescents with type 1 diabetes mellitus in Isfahan, Iran. J Diabetes Metab Disord. 2021;20(2):1281–8.CrossRefPubMedPubMedCentral Hashemipour M, Hovsepian S, Mozafarian N, Motaghi Z, Izadikhah E, Maracy MR. Factors related to glycemic control in children and adolescents with type 1 diabetes mellitus in Isfahan, Iran. J Diabetes Metab Disord. 2021;20(2):1281–8.CrossRefPubMedPubMedCentral
22.
go back to reference Kuznetsov L, Griffin SJ, Davies MJ, Lauritzen T, Khunti K, Rutten GE, et al. Diabetes-specific quality of life but not health status is independently associated with glycaemic control among patients with type 2 diabetes: a cross-sectional analysis of the ADDITION-Europe trial cohort. Diabetes Res Clin Pract. 2014;104(2):281–7.CrossRefPubMed Kuznetsov L, Griffin SJ, Davies MJ, Lauritzen T, Khunti K, Rutten GE, et al. Diabetes-specific quality of life but not health status is independently associated with glycaemic control among patients with type 2 diabetes: a cross-sectional analysis of the ADDITION-Europe trial cohort. Diabetes Res Clin Pract. 2014;104(2):281–7.CrossRefPubMed
23.
go back to reference Lind M, Pivodic A, Svensson AM, Ólafsdóttir AF, Wedel H, Ludvigsson J. HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: swedish population based cohort study. BMJ (Clinical research ed). 2019;366:l4894.PubMed Lind M, Pivodic A, Svensson AM, Ólafsdóttir AF, Wedel H, Ludvigsson J. HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: swedish population based cohort study. BMJ (Clinical research ed). 2019;366:l4894.PubMed
24.
go back to reference Alsuliman MA, Alotaibi SA, Zhang Q, Durgampudi PK. A systematic review of factors associated with uncontrolled diabetes and meta-analysis of its prevalence in Saudi Arabia since 2006. Diab/Metab Res Rev. 2021;37(3):e3395.CrossRef Alsuliman MA, Alotaibi SA, Zhang Q, Durgampudi PK. A systematic review of factors associated with uncontrolled diabetes and meta-analysis of its prevalence in Saudi Arabia since 2006. Diab/Metab Res Rev. 2021;37(3):e3395.CrossRef
25.
go back to reference Ayele BH, Roba HS, Beyene AS, Mengesha MM. Prevalent, uncontrolled, and undiagnosed diabetes mellitus among urban adults in Dire Dawa, Eastern Ethiopia: A population-based cross-sectional study. Sage Open Medicine. 2020;8. Ayele BH, Roba HS, Beyene AS, Mengesha MM. Prevalent, uncontrolled, and undiagnosed diabetes mellitus among urban adults in Dire Dawa, Eastern Ethiopia: A population-based cross-sectional study. Sage Open Medicine. 2020;8.
26.
go back to reference Jebril M, Liu X, Shi ZM, Mazidi M, Altaher A, Wang YF. Prevalence of type 2 diabetes and its association with added Sugar Intake in Citizens and Refugees aged 40 or older in the Gaza Strip, Palestine. Int J Environ Res Public Health. 2020;17:22.CrossRef Jebril M, Liu X, Shi ZM, Mazidi M, Altaher A, Wang YF. Prevalence of type 2 diabetes and its association with added Sugar Intake in Citizens and Refugees aged 40 or older in the Gaza Strip, Palestine. Int J Environ Res Public Health. 2020;17:22.CrossRef
27.
go back to reference Edqvist J, Rawshani A, Rawshani A, Adiels M, Franzén S, Bjorck L et al. Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset. BMJ open diabetes research & care. 2021;9(1). Edqvist J, Rawshani A, Rawshani A, Adiels M, Franzén S, Bjorck L et al. Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset. BMJ open diabetes research & care. 2021;9(1).
28.
go back to reference Moradi G, Shokri A, Mohamadi-Bolbanabad A, Zareie B, Piroozi B. Evaluating the quality of care for patients with type 2 diabetes mellitus based on the HbA1c: a national survey in Iran. Heliyon. 2021;7(3):e06485.CrossRefPubMedPubMedCentral Moradi G, Shokri A, Mohamadi-Bolbanabad A, Zareie B, Piroozi B. Evaluating the quality of care for patients with type 2 diabetes mellitus based on the HbA1c: a national survey in Iran. Heliyon. 2021;7(3):e06485.CrossRefPubMedPubMedCentral
Metadata
Title
The prevalence of uncontrolled diabetes mellitus in patients with type 2 diabetes: a multicenter cross-sectional study
Authors
Monir Lorestanifar
Masoomeh Mosayebi Molasaraei
Reyhaneh Jashaninejad
Saman Khoshmanesh
Amin Doosti-Irani
Publication date
17-03-2023
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2023
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-023-01201-9

Other articles of this Issue 1/2023

Journal of Diabetes & Metabolic Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine